BAUMER (BALM4) Main Indicators
Basic Data - BALM4
| Company | BAUMER |
| Corporate Name | BAUMER S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Tradicional - BOVESPA |
| Activity | Fabricação aparelhos e instrumentos p/ uso medico hospitalar e ortopedia |
| Share | BALM4 |
| Quote Date | 11/08/2024 |
| Share Type | PN |
| Last Closing | R$ 10.50 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 1.05 thousand |
| Last Statement | ITR - 06/30/2024 |
| Sector | Saúde |
| Subsector | Equipamentos |
| Segment | Equipamentos |
| Participation Indexes | - |
| Updated 11/09/2024 | |
Relative Prices - BALM4
| Price/Earnings | 7.49 |
| Price/SBV | 0.65 |
| Price/Net Sales | 0.62 |
| Price/CFO | 4.37 |
| Price/FCF | 6.01 |
| Price/Total Assets | 0.39 |
| Price/EBIT | 5.59 |
| Price/Working Capital | 0.86 |
| Price/NCAV | 7.26 |
| EV/EBIT | 6.67 |
| EV/EBITDA | 5.24 |
| EV/Net Sales | 0.74 |
| EV/CFO | 5.21 |
| EV/FCF | 7.17 |
| EV/Total Assets | 0.47 |
| Company Market Cap | R$ 117.11 M |
| Enterprise Value | R$ 122.77 M |
| Current Financial Statement Date | 06/30/2024 |
| Current Share Price | R$ 10.50 |
| Share Price Date | 11/08/2024 |
| Dividend Yield | 7.39% |
| Updated 11/09/2024 | |
Income Statement - BALM4
| Net Revenue | R$ 166.03 M |
| Gross Result | R$ 102.81 M |
| EBIT | R$ 18.41 M |
| Depreciation and Amortization | - R$ 5.00 M |
| EBITDA | R$ 23.41 M |
| Net Profit | R$ 13.74 M |
| Net Profit/Share | R$ 1.40 |
| Updated 08/14/2024 | |
| Net Revenue | R$ 46.03 M |
| Gross Result | R$ 26.96 M |
| EBIT | R$ 4.81 M |
| Depreciation and Amortization | - R$ 1.28 M |
| EBITDA | R$ 6.09 M |
| Net Profit | R$ 7.69 M |
| Profit/Share | R$ 0.78 |
| Updated 08/14/2024 | |
Price and Volume Behavior - BALM4
| Lowest Price 52 weeks | R$ 8.89 |
| Highest Price 52 weeks | R$ 11.52 |
| Variation 2024 | 4.90% |
| Variation 1 year | 12.43% |
| Variation 2 years(total) | 19.64% |
| Variation 2 years(yearly) | 9.37% |
| Variation 3 years(total) | -8.80% |
| Variation 3 years(yearly) | -3.02% |
| Variation 4 years(total) | -31.21% |
| Variation 4 years(yearly) | -8.91% |
| Variation 5 years(total) | 6.78% |
| Variation 5 years(yearly) | 1.32% |
| Average Daily Volume (3 months) | R$ 5.02 thousand |
| Updated 11/09/2024 | |
Returns and Margins - BALM4
| Return on Initial Tangible Capital | 6.83% |
| Return on Initial Invested Capital | 7.97% |
| Pre-Tax Return on Initial Tangible Capital | 10.35% |
| Pre-Tax Return on Initial Invested Capital | 12.08% |
| Return on Initial Shareholder´s Equity | 9.65% |
| Return on Initial Asset | 5.54% |
| Gross Margin | 61.93% |
| Net Margin | 8.28% |
| EBIT Margin | 11.09% |
| EBITDA Margin | 14.10% |
| Initial Asset Turnover | 0.67 |
| Financial Leverage | 1.67 |
| Liabilities/Net Worth | 0.67 |
| Net Debt/EBITDA | 0.24 |
| Updated 08/14/2024 | |
Balance Sheet - BALM4
| Cash and Cash Equivalents | R$ 12.63 M |
| Total Assets | R$ 263.44 M |
| Short-Term Debt | R$ 2.01 M |
| Long-Term Debt | R$ 16.28 M |
| Gross Debt | R$ 18.29 M |
| Net Debt | R$ 5.66 M |
| Shareholder´s Equity | R$ 157.92 M |
| Share Book Value | R$ 16.11 |
| Common Shares | 4,900,000 |
| Preferred Shares | 4,900,000 |
| Total | 9,800,000 |
| Common Shares in Treasury | 11,890 |
| Preferred Shares in Treasury | 3,600 |
| Total in Treasury | 15,490 |
| Common Shares (Except Treasury) | 4,888,110 |
| Preferred Shares (Except Treasury) | 4,896,400 |
| Total (Except Treasury) | 9,784,510 |
| Updated 08/14/2024 | |
Cash Flow - BALM4
| Operating Cash Flow | R$ 23.57 M |
| Cash Flow from Investments | - R$ 3.84 M |
| Financing Cash Flow | - R$ 6.02 M |
| Increase (Reduction) in Cash and Equivalents | R$ 13.70 M |
| Updated 08/14/2024 | |
| Operating Cash Flow | R$ 8.61 M |
| Cash Flow from Investments | - R$ 841.00 thousand |
| Financing Cash Flow | - R$ 3.74 M |
| Increase (Reduction) in Cash and Equivalents | R$ 4.03 M |
| Updated 08/14/2024 | |
Experimental - BALM4
| CAPEX 3 months | - R$ 1.60 M |
| Free Cash Flow 3 months | R$ 7.02 M |
| CAPEX 12 months | - R$ 6.45 M |
| Free Cash Flow 12 months | R$ 17.11 M |
| Updated 08/14/2024 | |